IFNL1 and COVID-19: For example, in the study by Phetsouphanh et al. [36], patients with long-COVID had highly activated innate immune cells, lacked naive T and B cells, and exhibited elevated expression of IFN-β and IFN-λ1 at 8 months post-COVID-19.